A recent study suggests that individuals who stop using new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt traditional lifestyle programs.
Published data in a major health publication points out that while overweight individuals often shed a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such treatments should be informed of the danger of rapid weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of regain means a reversion to original mass in about one and a half years.
Weighing Therapies
The analysis, which examined dozens of studies involving over 9,000 of participants, compared the effects of the injectable medications with older methods.
Scientists point out that individuals who shed pounds through dieting generally have a slower weight regain—approximately 100 grams monthly—once they finish.
Understanding the Rapid Regain
Experts believe the mechanism of the drugs accounts for the amplified regain.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement leads to appetite is unsuppressed, making binge eating much more probable."
A Lifelong Condition?
Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts argue that, considering the high risk of relapse, the therapy is often long-term.
This view is reinforced by pharmaceutical companies, who state that the findings "highlight the long-term character of excess weight," akin to managing diseases like hypertension.
Patient Accounts
Individuals who have stopped the medication explain a powerful return of appetite.
"It was like a trigger activating and you become ravenous," described an individual.
This difficulty is compounded if individuals have not adopted permanent dietary or behavioural modifications during treatment.
Growing Interest
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a magic cure and maintained weight loss hinges on ongoing lifestyle management.
